(Q45971982)

18 December 2017

title

Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. (English)

1 reference

18 December 2017

main subject

oleic monoethanolamide

1 reference

ChEBI release 2020-05-28

1

1 reference

18 December 2017

Raffaele Capasso

3

1 reference

18 December 2017

Vincenzo Di Marzo

7

1 reference

18 December 2017

Pietro Marini

object named as

Pietro Marini

4

0 references

Fabiana Piscitelli

object named as

Fabiana Piscitelli

2

0 references

author name string

Luigia Cristino

5

1 reference

18 December 2017

Stefania Petrosino

6

1 reference

18 December 2017

publication date

11 June 2009

1 reference

18 December 2017

published in

Obesity

1 reference

18 December 2017

volume

18

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

55-62

1 reference

18 December 2017

Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Peroxisome Proliferator-Activated Receptors, Fatty Acid Oxidation, Steatohepatitis and Hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Pleiotropic effects of fibrates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

PPARalpha in atherosclerosis and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Biological functions and metabolism of oleoylethanolamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

An anorexic lipid mediator regulated by feeding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

The lipid messenger OEA links dietary fat intake to satiety.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR alpha ligands in mouse pancreatic islets of Langerhans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Effect of PEA on LPS inflammatory action in human adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Anti-inflammatory effect of palmitoylethanolamide on human adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

CB(1) receptor antagonism: biological basis for metabolic effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

An introduction to the endocannabinoid system: from the early to the latest concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

PPARalpha and PPARgamma regulation of liver and adipose proteins in obese and dyslipidemic rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor- Agonist, Modulates Carrageenan-Induced Paw Edema in Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Expression of peroxisome proliferator-activated receptors in lean and obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Long-chain N-acylethanolamines inhibit lipid peroxidation in rat liver mitochondria under acute hypoxic hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

The endocannabinoid system is modulated in response to spinal cord injury in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Transcriptional regulation of the mouse fatty acid amide hydrolase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.186

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2009.186

1 reference

18 December 2017

PubMed ID

19521349

1 reference

18 December 2017